Literature DB >> 18356234

Diagnosis and management of motor neurone disease.

Christopher J McDermott1, Pamela J Shaw.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18356234      PMCID: PMC2270983          DOI: 10.1136/bmj.39493.511759.BE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  24 in total

1.  The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

2.  Stem cell treatment in Amyotrophic Lateral Sclerosis.

Authors:  Letizia Mazzini; Katia Mareschi; Ivana Ferrero; Elena Vassallo; Giuseppe Oliveri; Nicola Nasuelli; Gaia Donata Oggioni; Lucia Testa; Franca Fagioli
Journal:  J Neurol Sci       Date:  2007-06-19       Impact factor: 3.181

3.  Nutritional status is a prognostic factor for survival in ALS patients.

Authors:  J C Desport; P M Preux; T C Truong; J M Vallat; D Sautereau; P Couratier
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

4.  Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis.

Authors:  Yue-Mei Jiang; Masahiko Yamamoto; Yasushi Kobayashi; Tsuyoshi Yoshihara; Yideng Liang; Shinichi Terao; Hideyuki Takeuchi; Shinsuke Ishigaki; Masahisa Katsuno; Hiroaki Adachi; Jun-ichi Niwa; Fumiaki Tanaka; Manabu Doyu; Mari Yoshida; Yoshio Hashizume; Gen Sobue
Journal:  Ann Neurol       Date:  2005-02       Impact factor: 10.422

5.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.

Authors:  L Lacomblez; G Bensimon; P N Leigh; P Guillet; V Meininger
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

Review 6.  The epidemiology of motor neuron diseases: a review of recent studies.

Authors:  P M Worms
Journal:  J Neurol Sci       Date:  2001-10-15       Impact factor: 3.181

7.  Motor neurone disease: a hospice perspective.

Authors:  T O'Brien; M Kelly; C Saunders
Journal:  BMJ       Date:  1992-02-22

8.  Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

Authors:  B J Traynor; M Alexander; B Corr; E Frost; O Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

9.  Breaking the news in amyotrophic lateral sclerosis.

Authors:  G D Borasio; R Sloan; D E Pongratz
Journal:  J Neurol Sci       Date:  1998-10       Impact factor: 3.181

10.  Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death.

Authors:  E J Kasarskis; S Berryman; J G Vanderleest; A R Schneider; C J McClain
Journal:  Am J Clin Nutr       Date:  1996-01       Impact factor: 7.045

View more
  33 in total

1.  Identifying key signs of motor neurone disease in primary care: a nested case-control study using the QResearch database.

Authors:  Xue W Mei; Judith Burchardt; Tom A Ranger; Christopher J McDermott; Aleksandar Radunovic; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ Open       Date:  2022-06-28       Impact factor: 3.006

2.  The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis.

Authors:  Ping K Yip; Chiara Pizzasegola; Stacy Gladman; Maria Luigia Biggio; Marianna Marino; Maduka Jayasinghe; Farhan Ullah; Simon C Dyall; Andrea Malaspina; Caterina Bendotti; Adina Michael-Titus
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

3.  Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].

Authors:  Ammar Al-Chalabi; Pamela J Shaw; Carolyn A Young; Karen E Morrison; Caroline Murphy; Marie Thornhill; Joanna Kelly; I Nicholas Steen; P Nigel Leigh
Journal:  BMC Neurol       Date:  2011-09-21       Impact factor: 2.474

4.  Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions.

Authors:  Rohini Raman; Scott P Allen; Emily F Goodall; Shelley Kramer; Lize-Linde Ponger; Paul R Heath; Marta Milo; Hannah C Hollinger; Theresa Walsh; J Robin Highley; Simon Olpin; Christopher J McDermott; Pamela J Shaw; Janine Kirby
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

5.  Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study.

Authors: 
Journal:  Lancet Neurol       Date:  2015-05-28       Impact factor: 44.182

6.  Establishing the UK DNA Bank for motor neuron disease (MND).

Authors:  Lucy Smith; B C Cupid; B G M Dickie; A Al-Chalabi; K E Morrison; C E Shaw; P J Shaw
Journal:  BMC Genet       Date:  2015-07-14       Impact factor: 2.797

7.  Protocol for diaphragm pacing in patients with respiratory muscle weakness due to motor neurone disease (DiPALS): a randomised controlled trial.

Authors:  Christopher J McDermott; Chin Maguire; Cindy L Cooper; Roger Ackroyd; Wendy O Baird; Simon Baudouin; Andrew Bentley; Stephen Bianchi; Stephen Bourke; Mike J Bradburn; Simon Dixon; John Ealing; Simon Galloway; Dayalan Karat; Nick Maynard; Karen Morrison; Naveed Mustfa; John Stradling; Kevin Talbot; Tim Williams; Pamela J Shaw
Journal:  BMC Neurol       Date:  2012-08-16       Impact factor: 2.474

8.  Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (ANG) mutation.

Authors:  J Kirby; J R Highley; L Cox; E F Goodall; C Hewitt; J A Hartley; H C Hollinger; M Fox; P G Ince; C J McDermott; P J Shaw
Journal:  Neuropathol Appl Neurobiol       Date:  2013-08       Impact factor: 8.090

Review 9.  Brown-Vialetto-Van Laere syndrome.

Authors:  Sivakumar Sathasivam
Journal:  Orphanet J Rare Dis       Date:  2008-04-17       Impact factor: 4.123

10.  Activation of ER Stress and Autophagy Induced by TDP-43 A315T as Pathogenic Mechanism and the Corresponding Histological Changes in Skin as Potential Biomarker for ALS with the Mutation.

Authors:  Xuejing Wang; Shuang Zhou; Xuebing Ding; Mingming Ma; Jiewen Zhang; Yue Zhou; Erxi Wu; Junfang Teng
Journal:  Int J Biol Sci       Date:  2015-07-21       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.